XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 2,483 $ 4,544
Receivables 52 47
Inventories:    
Leaf tobacco 609 744
Other raw materials 189 166
Work in process 27 23
Finished product 281 261
Inventory, net 1,106 1,194
Other current assets 379 298
Total current assets 4,020 6,083
Property, plant and equipment, at cost 4,409 4,432
Less accumulated depreciation 2,822 2,879
Property, plant and equipment, net 1,587 1,553
Goodwill 5,177 5,177
Other intangible assets, net 12,353 12,306
Investments in equity securities ($351 million and $1,720 million at September 30, 2022 and December 31, 2021, respectively, measured at fair value) 9,814 13,481
Other assets 1,002 923
Total Assets 33,953 39,523
Liabilities    
Current portion of long-term debt 1,443 1,105
Accounts payable 417 449
Accrued liabilities:    
Marketing 691 664
Settlement charges 2,731 3,349
Other 1,122 1,365
Dividends payable 1,693 1,647
Total current liabilities 8,097 8,579
Long-term debt 24,848 26,939
Deferred income taxes 3,330 3,692
Accrued pension costs 196 200
Accrued postretirement health care costs 1,436 1,436
Other liabilities 278 283
Total liabilities 38,185 41,129
Contingencies (Note 11)
Stockholders’ Equity (Deficit)    
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued) 935 935
Additional paid-in capital 5,873 5,857
Earnings reinvested in the business 28,785 30,664
Accumulated other comprehensive losses (2,383) (3,056)
Cost of repurchased stock (1,012,146,048 shares at September 30, 2022 and 982,785,699 shares at December 31, 2021) (37,442) (36,006)
Total stockholders’ equity (deficit) (4,232) (1,606)
Total Liabilities and Stockholders’ Equity (Deficit) $ 33,953 $ 39,523